| Document Date: 2014-01-17 12:57:49
Open Document File Size: 150,93 KBShare Result on Facebook
City Montreal / Ottawa / / Company Bristol-Myers Squibb Canada / ImClone LLC / / Country United States / Canada / / / / IndustryTerm therapy for metastatic colorectal cancer / mg/mL solution / / MedicalCondition heart arrhythmia / e.g. wheezing / loss of consciousness / lungs causing coughing / chest pain / headache / colorectal cancer / hives / metastasis / heart disease / pulmonary fibrosis / low blood pressure / lung disease / miscarriage / diarrhea / angina / cardiac arrest / infections / wheezing / severe allergic reactions / EGFR-expressing metastatic cancer / squamous cell carcinoma / cancer / Cardiopulmonary Arrest / kidney disease / hoarseness / chills / bad reaction/allergy / shock / tumour / Metastatic colorectal cancer / especially interstitial pneumonitis / itching / fever / sunburn / heart failure / heart attack / allergic reactions / coronary artery disease / infection / allergic/hypersensitivity / inflammation / rash / syndrome / / MedicalTreatment radiation therapy / birth control / chemotherapy / / Organization Health Products and Food Branch / / / Position pharmacist / physician / / Product sodium chloride / PROPER USE OF THIS MEDICATION / INTERACTIONS WITH THIS MEDICATION / THIS MEDICATION / ERBITUX / fluorouracil / / Technology radiation / antibodies / chemotherapy / / URL www.healthcanada.gc.ca/medeffect / /
SocialTag |
IMPORTANT: PLEASE READ tolerate other irinotecan-based chemotherapy. PART III: CONSUMER INFORMATION In patients who cannot tolerate irinotecan. In patients who have failed on both irinotecan- and Pr